Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...
OpenAI’s internal AI data agent searches 600 petabytes across 70,000 datasets, saving hours per query and offering a blueprint for enterprise AI agents.
AI systems are beginning to build and improve themselves. But without a verification layer, trust, safety and accountability ...
Chief Commercial Officer David Lin reported, “ZUSDURI generated $1.8 million in net product revenue in Q3, and $14 million in Q4, bringing full year 2025 revenue to $15.8 million,” and detailed ...
Urogen Pharma (NASDAQ:URGN) executives used the company’s fiscal 2025 earnings call to highlight early commercial momentum for newly launched Zusduri, continued growth from its established product ...
GitLab Inc. ( GTLB) Q4 2026 Earnings Call March 3, 2026 4:30 PM EST Good day, everyone, and welcome to today's GitLab Fourth Quarter Fiscal Year 2026 Conference Call. [Operator Instructions] Please ...
Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...
When your AI assistant calculates revenue, bonuses, VAT or financial summaries, it isn’t doing math. It’s telling a convincing story about numbers.
Check out all Craft Anime recipes here, along with the steps for crafting, element details, and mutation multipliers.
With Kaveri, QpiAI scales up from its 25-qubit Indus system to a 64-qubit superconducting processor built in India.
EDA produces a lot of data, but how useful is that for AI to consume? The industry looks at new ways to help AI do a better job.
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results